ARCHIVES

In Brief: Columbia’s Marks Reportedly Will Move To MSK; FDA Committee to Consider THC For Group C List

This article is from The Cancer Letter archive.

Vol. 06 No. 21 | May 23, 1980

Download PDF Visit The Full Archive

Related Articles

Also in This 8-page Issue: In Overhaul of Ethics Rules, NIH Bans Employees From Consulting for and Owning Stock in Biomedical Companies.

February 4, 2005

GAO Eppley Report Offers Lessons for Grantees, Contractors

March 3, 1978

DCPC Board Approves Concepts For New Master Agreement, Recompetitions

October 9, 1987

MIT’s Sharp To Head Biology Dept.; Hynes To Head Cancer Center

April 12, 1991

Kessler Says FDA Working To Expedite Secondary Approvals

January 31, 1992

ORI Finds Misconduct By Harvard Physician On Cancer Protocol; Two Other Cases

June 9, 1995